ABSTRACT BACKGROUND: Screening for probable and confirmed sarcopenia using sociodemographic and anthropometric indicators can be a practical, cheap, and effective strategy to identify and treat older people susceptible to this condition. OBJECTIVES: To identify cutoff points for sociodemographic and anthropometric variables in screening probable and confirmed sarcopenia in community-dwelling older adults. DESIGN AND SETTING: This was a cross-sectional study of community-dwelling older adults in Araranguá, Santa Catarina, Brazil. METHODS: Sociodemographic (age, education) and anthropometric (weight, height, body mass index [BMI], waist circumference [WC], and dominant calf circumference [DCC]) factors were considered as predictors. The outcomes were probable sarcopenia (reduction in muscle strength assessed by time ≥ 15 s in the five-time sit-to-stand test) and confirmed sarcopenia (reduction in strength and muscle mass). Receiver operating characteristic curve analysis was used to analyze the ability to track sociodemographic and anthropometric variables for sarcopenia. RESULTS: In 308 older adults, WC > 91 cm in women and age > 69 years in men were useful in screening for probable sarcopenia. The variables age, weight, BMI, WC, and DCC can be used to screen for sarcopenia in older women and men. CONCLUSION: Sociodemographic and anthropometric variables are simple and accessible tools for sarcopenia screening in older adults. BACKGROUND practical cheap condition OBJECTIVES communitydwelling community dwelling SETTING crosssectional cross sectional Araranguá Catarina Brazil METHODS (age education weight (weight height BMI , [BMI] [WC] [DCC] predictors reduction 1 fivetime five sittostand sit stand test mass. . mass) RESULTS 30 9 6 CONCLUSION [BMI [WC [DCC 3

RESUMEN Dada una laguna en la literatura con respecto a la ecuación para predecir el consumo máximo de oxígeno (VO2) en adolescentes de ambos sexos, el objetivo de este estudio es proponer una ecuación para predecir el VO2máximo en adolescentes sanos usando el shuttle test modificado (MST). Se trata de un estudio transversal, realizado con 84 adolescentes sanos con edades entre 12 y 18 años, de ambos sexos. El MST es una prueba de campo dictada por una señal sonora que indica el aumento de velocidad cada minuto. Se realizaron dos MST con al menos 30 minutos de descanso entre ellos. Para el análisis se consideró la prueba con mayor distancia recorrida. El monitoreo del VO2 fue realizado directamente por espirometría de circuito abierto. La edad media fue de 14,67±1,82 años; y la distancia recorrida, de 864,86±263,48m. Las variables incluidas en la ecuación de predicción fueron la distancia recorrida y el sexo, que explicaron el 53% de la variabilidad del VO2máximo durante la realización del MST. La ecuación de referencia para el VO2máximo predicho con el MST fue VO2máximo previsto=18,274+(0,18×Distancia recorrida, en metros)+(7,733×Sexo); R2=0,53 y p<0,0001 (sexo: 0 para chicas, 1 para chicos). La ecuación MST propuesta para predecir el VO2máximo en adolescentes sanos de ambos sexos puede utilizarse como una referencia para evaluar la capacidad de ejercicio en adolescentes sanos y para investigar la función cardiopulmonar en adolescentes con capacidad funcional reducida. VO (VO2 VOmáximo . (MST) transversal 8 años minuto 3 ellos abierto 1467182 14 67 82 14,67±1,8 8648626348m m 864 86 263 48m 864,86±263,48m sexo 53 previsto=18,274+0,18×Distancia previsto18274018Distancia previstoDistancia previsto=18,274+ 0,18×Distancia previsto 274 Distancia metros+7,733×Sexo metros7733Sexo metrosSexo metros + 7,733×Sexo 7 733 Sexo metros)+(7,733×Sexo) R2053 R R2 R2=0,5 p00001 p 0001 p<0,000 (sexo chicas chicos. chicos chicos) reducida (VO (MST 146718 6 14,67±1, 26 5 previsto18274 previsto=18,274 018Distancia 27 7733Sexo 73 metros)+(7,733×Sexo R205 R2=0, p0000 000 p<0,00 14671 14,67±1 2 previsto1827 previsto=18,27 R20 R2=0 p000 00 p<0,0 1467 14,67± previsto182 previsto=18,2 R2= p00 p<0, 146 14,67 previsto18 previsto=18, p0 p<0 14,6 previsto1 previsto=18 p< 14, previsto=1 previsto=

ABSTRACT Given the gap in the literature regarding the peak of oxygen consumption (VO2peak) for adolescents of both sexes, this study aimed to propose an equation to predict the VO2peak in healthy adolescents using the Modified Shuttle Test (MST). This is a cross-sectional study with 84 healthy adolescents between 12 and 18 years old, female and male. The MST is an external paced test, in which the speed increases at each minute. Two MST were performed with at least 30 minutes of rest between them. The test with the longest walked distance was considered for analysis. VO2 was directly monitored by an open circuit spirometry. Mean age was 14.67±1.82 and the walked distance was 864.86±263.48m. Variables included in the prediction equation were walked distance and sex, explaining the VO2peak variability of 53% during MST performance. The prediction equation for VO2peak with the MST was: predicted VO2peak=18.274+(0.18×Distance Walked, meters)+(7.733×Sex); R2=0.53 and p<0.0001 (sex: 0 for girls, 1 for boys). This MST equation, proposed to predict VO2peak in healthy adolescents of both sexes, can be used as a reference to assess exercise capacity in healthy adolescents and to investigate cardiopulmonary function in adolescents with reduced functional capacity. VOpeak VO (VO2peak sexes MST. . (MST) crosssectional cross sectional 8 old male minute 3 them analysis spirometry 1467182 14 67 82 14.67±1.8 8648626348m m 864 86 263 48m 864.86±263.48m sex 53 performance VO2peak=18.274+0.18×Distance VO2peak18274018Distance VOpeakDistance VO2peak=18.274+ 0.18×Distance 274 Distance Walked meters+7.733×Sex meters7733Sex metersSex meters + 7.733×Sex 7 733 Sex meters)+(7.733×Sex) R2053 R R2 R2=0.5 p00001 p 0001 p<0.000 (sex girls boys. boys boys) (MST 146718 6 14.67±1. 26 5 VO2peak18274 VO2peak=18.274 018Distance 27 7733Sex 73 meters)+(7.733×Sex R205 R2=0. p0000 000 p<0.00 14671 14.67±1 2 VO2peak1827 VO2peak=18.27 R20 R2=0 p000 00 p<0.0 1467 14.67± VO2peak182 VO2peak=18.2 R2= p00 p<0. 146 14.67 VO2peak18 VO2peak=18. p0 p<0 14.6 VO2peak1 VO2peak=18 p< 14. VO2peak=1 VO2peak=

RESUMO Dada a lacuna na literatura quanto à equação de predição do pico de consumo de oxigênio (VO2) para adolescentes de ambos os sexos, o objetivo deste estudo é propor uma equação para predizer o VO2pico em adolescentes saudáveis utilizando o shuttle test modificado (MST). Trata-se de um estudo transversal realizado com 84 adolescentes saudáveis entre 12 e 18 anos, do sexo feminino e masculino. O MST é um teste de campo ditado por um sinal sonoro que indica o aumento da velocidade a cada minuto. Dois MSTs foram realizados com pelo menos 30 minutos de descanso entre eles. O teste com a maior distância percorrida foi o considerado para análise. O VO2 foi monitorado diretamente por uma espirometria de circuito aberto. A média de idade foi de 14,67±1,82 anos, e a de distância percorrida foi de 864,86±263,48m. As variáveis incluídas na equação de predição foram distância percorrida e sexo, que explicaram 53% da variabilidade do VO2pico durante a realização do MST. A equação de referência para o VO2pico previsto com o MST foi VO2pico predito=18,274+(0,18×Distância percorrida, em metros)+(7,733×Sexo); R2=0,53 e p<0,0001 (sexo: 0 para meninas, 1 para meninos). A equação do MST proposta para predizer o VO2pico em adolescentes saudáveis de ambos os sexos pode ser usada como referência para avaliar a capacidade de exercício em adolescentes saudáveis e investigar a função cardiopulmonar em adolescentes com capacidade funcional reduzida. VO (VO2 VOpico . (MST) Tratase Trata se 8 anos masculino minuto 3 eles análise aberto 1467182 14 67 82 14,67±1,8 8648626348m m 864 86 263 48m 864,86±263,48m 53 predito=18,274+0,18×Distância predito18274018Distância preditoDistância predito=18,274+ 0,18×Distância predito 274 Distância metros+7,733×Sexo metros7733Sexo metrosSexo metros + 7,733×Sexo 7 733 Sexo metros)+(7,733×Sexo) R2053 R R2 R2=0,5 p00001 p 0001 p<0,000 (sexo meninas meninos. meninos meninos) reduzida (VO (MST 146718 6 14,67±1, 26 5 predito18274 predito=18,274 018Distância 27 7733Sexo 73 metros)+(7,733×Sexo R205 R2=0, p0000 000 p<0,00 14671 14,67±1 2 predito1827 predito=18,27 R20 R2=0 p000 00 p<0,0 1467 14,67± predito182 predito=18,2 R2= p00 p<0, 146 14,67 predito18 predito=18, p0 p<0 14,6 predito1 predito=18 p< 14, predito=1 predito=

ABSTRACT Symptoms in post-COVID-19 patients who require hospitalization can persist for months, significantly affecting their health-related quality of life (HRQoL). Thus, the present study aimed to discuss the main findings regarding HRQoL in post-COVID-19 patients who required hospitalization. An electronic search was performed in the MEDLINE, EMBASE, CINAHL, Web of Science, LILACS, and Scopus databases, without date and language restrictions, until July 2021. Twenty-four articles were included in the analysis. It seems that HRQoL partially improved soon after hospital discharge, although the negative impact on HRQoL may persist for months. The physical and mental aspects are affected because patients report pain, discomfort, anxiety, and depression. The HRQoL of COVID-19 infected patients was worse than that of uninfected patients. Additionally, HRQoL seemed worse in patients admitted to the intensive care unit than in those who remained in the ward. Improvements in HRQoL after hospital discharge are independent of imaging improvement, and there seems to be no association between HRQoL after hospital discharge and disease severity on hospital admission. Many factors have been identified as determinants of HRQoL, with women and advanced age being the most related to worse HRQOL, followed by the duration of invasive mechanical ventilation and the need for intensive care. Other factors included the presence and number of comorbidities, lower forced vital capacity, high body mass index, smoking history, undergraduate education, and unemployment. In conclusion, these findings may aid in clinical management and should be considered in the aftercare of patients.

ABSTRACT Patients with Chagas disease have reduced health-related quality of life (HRQoL). Hence, we aimed to identify the factors that mostly affected their HRQoL. This was a systematic review of qualitative studies. The Latin American and Caribbean Health Sciences Literature, Medical Literature Analysis and Retrieval System Online, Excerpta Medica Database, Web of Science, and SciVerse Scopus databases were searched for relevant studies without language or date restrictions. The search and data analysis were performed by independent reviewers; all qualitative studies that reported the factors that had an impact on the HRQoL of patients with Chagas disease were included. The risk of bias was assessed using the Critical Appraisal Skills Program Qualitative Study Checklist; confidence in the evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation-Confidence in the Evidence from Reviews of Qualitative approach. Five studies were included in this review: four in Brazil and one in California, United States, with immigrants from Central and South America. The sample consisted of 207 patients with chronic Chagas disease. Stigma, physical limitations, work absenteeism, emotional or mental aspects, fear of treatment, and fear of the future had the strongest impact on the HRQoL. All items showed moderate confidence except for fear of treatment (low confidence). The physical, emotional, mental, and cultural aspects affected the HRQoL of patients with chronic Chagas disease. Identification of these factors is important in the development of strategies aimed at improving the HRQoL of this population.

ABSTRACT BACKGROUND: Screening for probable and confirmed sarcopenia using sociodemographic and anthropometric indicators can be a practical, cheap, and effective strategy to identify and treat older people susceptible to this condition. OBJECTIVES: To identify cutoff points for sociodemographic and anthropometric variables in screening probable and confirmed sarcopenia in community-dwelling older adults. DESIGN AND SETTING: This was a cross-sectional study of community-dwelling older adults in Araranguá, Santa Catarina, Brazil. METHODS: Sociodemographic (age, education) and anthropometric (weight, height, body mass index [BMI], waist circumference [WC], and dominant calf circumference [DCC]) factors were considered as predictors. The outcomes were probable sarcopenia (reduction in muscle strength assessed by time ≥ 15 s in the five-time sit-to-stand test) and confirmed sarcopenia (reduction in strength and muscle mass). Receiver operating characteristic curve analysis was used to analyze the ability to track sociodemographic and anthropometric variables for sarcopenia. RESULTS: In 308 older adults, WC > 91 cm in women and age > 69 years in men were useful in screening for probable sarcopenia. The variables age, weight, BMI, WC, and DCC can be used to screen for sarcopenia in older women and men. CONCLUSION: Sociodemographic and anthropometric variables are simple and accessible tools for sarcopenia screening in older adults.

Resumo Esta revisão sistemática objetivou discutir os principais achados sobre a confiabilidade e validade dos questionários de qualidade de vida relacionada à saúde na insuficiência venosa crônica. A busca foi realizada nas bases de dados MEDLINE, CINAHL, Web of Science, LILACS e Scopus. Os termos de busca foram relacionados a “insuficiência venosa” e “qualidade de vida”. O Chronic Lower Limb Venous Insufficiency Questionnaire (CIVIQ)-20 e o CIVIQ-14 apresentaram consistência interna adequada e foram capazes de discriminar a gravidade da doença. O Venous Insufficiency Epidemiological and Economic Study – Quality of Life (VEINES-QoL) apresentou consistência interna adequada, mas não foi capaz de discriminar a gravidade da doença. A maioria dos estudos não demonstrou associação do VEINES-QoL com o componente mental do Short Form Health Survey (SF-36). O Aberdeen Varicose Vein Questionnaire (AVVQ) apresentou confiabilidade inadequada e validade duvidosa quando comparado ao SF-36. O VARIShort demonstrou consistência interna, reprodutibilidade e validade boas, mas apenas o estudo original foi incluído. Na úlcera venosa, o Charing Cross Venous Ulcer Questionnaire (CCVUQ) apresentou confiabilidade e validade adequadas quando comparado ao Venous Leg Ulcer Quality of Life (VLU-QoL).

Abstract This systematic review aimed to discuss the main findings regarding the reliability and validity of health-related quality of life questionnaires for chronic venous insufficiency. Searches were performed on the MEDLINE, CINAHL, Web of Science, LILACS, and Scopus databases. The search terms used were related to “venous insufficiency”, and “quality of life”. The CIVIQ-20 and CIVIQ-14 instruments had adequate internal consistency and both were able to discriminate disease severity. The VEINES-QoL showed adequate internal consistency but was not able to discriminate disease severity. Most studies did not demonstrate a correlation between VEINES-QoL and the mental component of the SF-36. The AVVQ had inadequate reliability but its validity was also doubtful when compared to the SF-36. The VARIShort demonstrated good internal consistency, reproducibility, and validity, but only the original study was included. For venous leg ulcers, the CCVUQ showed adequate reliability and validity when compared to VLU-QoL.

Resumo Fundamento: A doença de Chagas leva à redução da capacidade funcional. Entretanto, o estágio em que o comprometimento funcional é detectável permanece obscuro. Objetivos: O presente estudo teve como objetivo comparar a capacidade funcional de pacientes em diferentes estágios da doença de Chagas e de indivíduos saudáveis e verificar os determinantes do consumo de oxigênio de pico (VO2pico). Métodos: Em um estudo transversal, foram selecionados 160 indivíduos, 35 saudáveis e 125 com doença de Chagas. No grupo chagásico, 61 (49%) estavam na forma indeterminada da doença, 45 (36%) com cardiomiopatia chagásica (CC) e função cardíaca preservada e 19 (15%) com disfunção cardíaca e CC dilatada. Os dados foram analisados por meio de análise de regressão univariada e multivariada. A significância estatística foi fixada em 5%. Resultados: Pacientes na forma indeterminada da doença apresentaram capacidade funcional semelhante a indivíduos saudáveis (p> 0,05). Pacientes com ChC e função cardíaca preservada apresentaram VO2pico menor que os pacientes na forma indeterminada (p <0,05), mas apresentaram valores de VO2pico semelhantes ao ChC dilatado (p = 0,46). A idade, sexo masculino, classe funcional da NYHA, pressão arterial diastólica, razão entre a velocidade do fluxo transmitral diastólico precoce e a velocidade anular mitral diastólica precoce, a fração de ejeção do ventrículo esquerdo (FEVE) e o diâmetro diastólico final do ventrículo esquerdo foram associados à capacidade funcional. Porém, apenas idade, sexo masculino, FEVE e classe funcional da NYHA permaneceram associados ao VO2pico no modelo final (R2 ajustado = 0,60). Conclusão: Pacientes com CC apresentam menor capacidade funcional do que pacientes na forma indeterminada. FEVE, idade, sexo masculino e classe funcional da NYHA foram determinantes do VO2pico em pacientes com doença de Chagas.

Abstract Background: Chagas disease leads to reduced functional capacity. However, the stage at which functional impairment is detectable remains unclear. Objectives: The present study was addressed to compare the functional capacity of patients at different stages of Chagas disease and healthy individuals and to verify the determinants of peak oxygen uptake (VO2peak). Methods: In a cross-sectional study, 160 individuals were selected, 35 healthy and 125 with Chagas disease. In the Chagasic group, 61 (49%) were in the indeterminate form of the disease, 45 (36%) with Chagas cardiomyopathy (ChC) and preserved cardiac function and 19 (15%) with cardiac dysfunction and dilated ChC. The data were analyzed using univariate and multivariate regression analysis. Statistical significance was set at 5%. Results: Patients in the indeterminate form of disease showed similar functional capacity to healthy individuals (p>0.05). Patients with ChC and preserved cardiac function had lower VO2peak than patients in the indeterminate form (p<0.05), but showed similar VO2peak values than dilated ChC (p=0.46). The age, male sex, NYHA functional class, diastolic blood pressure, ratio of the early diastolic transmitral flow velocity to early diastolic mitral annular velocity, left ventricular ejection fraction (LVEF) and left ventricular end-diastolic diameter were associated with functional capacity. However, only age, male sex, LVEF and NYHA functional class, remained associated with VO2peak in the final model (adjusted R2=0.60). Conclusion: Patients with ChC had lower functional capacity than patients in the indeterminate form. LVEF, age, male sex and NYHA functional class were determinants with VO2peak in patients with Chagas disease.

Abstract This article aims to evaluate the sleep quality in individuals during the COVID-19 pandemic by Pittsburgh Sleep Quality Index (PSQI). Searches were conducted in the PubMed, Embase, Web of Science, and PEDro databases, on May 22, 2020. In the publications, 208 articles were found and, considering the eligibility criteria, 10 articles were included at the end, showing the effects on sleep quality during the pandemic, in populations hospitalized, quarantined, and in frontline health professionals. The PSQI measured sleep disorders and a higher score indicated poor sleep quality. Nine articles were classified with evidence level IV and one as level III-2. Eight studies present a “serious” risk of bias and two in “moderate”. The studies investigated different populations and described the results as “poor” sleep quality, considering the PSQI on quarantined individuals and frontline health professionals as the most committed. A poor sleep quality was found in the populations evaluated in the selected publications, probably, due to the COVID-19 to contribute as a risk factor for mental health. Psychological interventions must be made to minimize the consequences through social support and social capital. COVID19 COVID 19 COVID-1 PSQI. . (PSQI) PubMed Embase Science databases 22 2020 publications 20 criteria 1 end hospitalized III2. III2 III 2. 2 III-2 serious “serious moderate. moderate “moderate” “poor committed probably capital COVID1 COVID- (PSQI 202 III- “moderate

Resumo O objetivo deste artigo é avaliar a qualidade do sono em indivíduos durante a pandemia de COVID-19 pelo Índice de Qualidade do Sono de Pittsburgh (IQSP). Buscas foram realizadas nas bases de dados PubMed, Embase, Web of Science e PEDro, em 22 de maio de 2020. Nas publicações, foram encontrados 208 artigos e, considerando os critérios de elegibilidade, foram incluídos ao final 10 artigos, mostrando os efeitos na qualidade do sono durante a pandemia, em populações hospitalizadas, em quarentena e em profissionais de saúde. O IQSP mediu os distúrbios do sono e uma pontuação mais alta indicava uma má qualidade do sono. Foram classificados nove artigos com nível de evidência IV e um como nível III-2. Oito estudos apresentaram um risco de viés “crítico” e dois em “moderado”. Os estudos investigaram diferentes populações e descreveram os resultados como uma má qualidade do sono, considerando o IQSP, sendo os titulares de quarentena e profissionais de saúde como os mais comprometidos. Foi encontrado uma má qualidade do sono nas populações avaliadas nas publicações selecionadas, provavelmente, devido ao COVID-19 contribuir como um fator de risco para saúde mental. Intervenções psicológicas devem ser feitas para minimizar as consequências através do apoio social e capital social. COVID19 COVID 19 COVID-1 IQSP. . (IQSP) PubMed Embase PEDro 2 2020 20 elegibilidade 1 hospitalizadas III2. III2 III 2. III-2 crítico “crítico moderado. moderado “moderado” comprometidos selecionadas provavelmente mental COVID1 COVID- (IQSP 202 III- “moderado

Resumo O objetivo deste artigo é avaliar a qualidade do sono em indivíduos durante a pandemia de COVID-19 pelo Índice de Qualidade do Sono de Pittsburgh (IQSP). Buscas foram realizadas nas bases de dados PubMed, Embase, Web of Science e PEDro, em 22 de maio de 2020. Nas publicações, foram encontrados 208 artigos e, considerando os critérios de elegibilidade, foram incluídos ao final 10 artigos, mostrando os efeitos na qualidade do sono durante a pandemia, em populações hospitalizadas, em quarentena e em profissionais de saúde. O IQSP mediu os distúrbios do sono e uma pontuação mais alta indicava uma má qualidade do sono. Foram classificados nove artigos com nível de evidência IV e um como nível III-2. Oito estudos apresentaram um risco de viés “crítico” e dois em “moderado”. Os estudos investigaram diferentes populações e descreveram os resultados como uma má qualidade do sono, considerando o IQSP, sendo os titulares de quarentena e profissionais de saúde como os mais comprometidos. Foi encontrado uma má qualidade do sono nas populações avaliadas nas publicações selecionadas, provavelmente, devido ao COVID-19 contribuir como um fator de risco para saúde mental. Intervenções psicológicas devem ser feitas para minimizar as consequências através do apoio social e capital social.

Abstract This article aims to evaluate the sleep quality in individuals during the COVID-19 pandemic by Pittsburgh Sleep Quality Index (PSQI). Searches were conducted in the PubMed, Embase, Web of Science, and PEDro databases, on May 22, 2020. In the publications, 208 articles were found and, considering the eligibility criteria, 10 articles were included at the end, showing the effects on sleep quality during the pandemic, in populations hospitalized, quarantined, and in frontline health professionals. The PSQI measured sleep disorders and a higher score indicated poor sleep quality. Nine articles were classified with evidence level IV and one as level III-2. Eight studies present a “serious” risk of bias and two in “moderate”. The studies investigated different populations and described the results as “poor” sleep quality, considering the PSQI on quarantined individuals and frontline health professionals as the most committed. A poor sleep quality was found in the populations evaluated in the selected publications, probably, due to the COVID-19 to contribute as a risk factor for mental health. Psychological interventions must be made to minimize the consequences through social support and social capital.

Abstract Patients with Chagas cardiomyopathy (ChC) usually progress with fatigue and dyspnea. Exercise tests are valuable for the functional evaluation of these patients. However, information about the applicability of the exercise tests is scattered, and no studies have systematically reviewed the results. Thus, the present review explored the general aspects and prognostic value of exercise tests in patients with ChC. A literature search of the MEDLINE, Web of Science, CINAHL, Scopus, and LILACS databases was performed to identify relevant studies. There were no data restrictions, and articles that met the objective of the study were selected. Articles written in English, Portuguese, and Spanish were considered, and 25 articles were finally included. The peak oxygen uptake (VO2peak) was correlated with demographic and echocardiographic variables. Echocardiographic features of the left ventricular diastolic function and right ventricular systolic function appeared to be determinants of functional capacity, in addition to age and sex. VO2peak was associated with higher mortality, especially in patients with dilated ChC. The minute ventilation/carbon dioxide production slope (VE/VCO2 slope) was a strong predictor of survival; however, more studies are needed to verify this observation. Field tests showed moderate to strong correlation with VO2peak and thus may be inexpensive tools for the functional evaluation of patients with ChC. However, few studies have verified their prognostic significance. While exercise tests are useful tools for functional assessment, information is scarce regarding further considerations, and many of the criteria are based on guidelines for other heart diseases.

Resumo Introdução O sobrepeso e a obesidade infantil representam alguns dos principais problemas de saúde pública no mundo, porém se observa escassez de registros de prevalência no Brasil no primeiro ano de vida. Objetivo Verificar a prevalência de sobrepeso e de obesidade no primeiro ano de vida das crianças cadastradas nas Estratégias Saúde da Família e identificar se existe diferença entre os índices peso por idade, estatura por idade, peso/estatura por idade e índice de massa corporal (IMC) por idade em relação ao sexo, à faixa etária e ao nível socioeconômico. Método Estudo transversal, com dados de peso e estatura coletados da Caderneta de Saúde da Criança. Resultados A prevalência de sobrepeso e de obesidade foi de 7,2% pelo índice peso/estatura e de 4,8% pelo IMC. Crianças com nível socioeconômico A-B apresentaram maior IMC por idade quando comparadas às crianças do nível C (p = 0,048). Crianças entre 6 e 12 meses de idade apresentaram valores superiores de peso por idade (p = 0,02) e estatura por idade (p = 0,01) quando comparadas às crianças menores de 6 meses. Conclusão A prevalência de sobrepeso e de obesidade das crianças no primeiro ano de vida depende do índice utilizado para classificação. O nível socioeconômico pode interferir nos valores do IMC por idade, enquanto a faixa etária pode interferir nos índices peso por idade e estatura por idade.

Abstract Background Childhood overweight and obesity represent one of the main public health problems in the world, but there is a scarcity of prevalence records in Brazil during the first year of life. Objective Verify the prevalence of overweight and obesity in the first year of life of infants enrolled in the Family Health Strategies, and to identify whether there is a difference in weight-per-age, height-per-age, weight/height-per-age and body mass index (BMI)-per-age in relation to sex, age group and socioeconomic level. Method A cross-sectional study was performed, in which weight and height data were collected from the Child Health Handbook. Results The prevalence of overweight and obesity was 7.2% according to the weight/height index, and 4.8% for the BMI index. Infants with an A-B socioeconomic status had higher BMI-per-age when compared to children at level C (p=0.048). Infants aged 6 to 12 months had higher weight-per-age (p=0.02) and height-per-age (p=0.01) than infants younger than six months. Conclusion The prevalence of overweight and obesity in the first year of life depends on the index used for classification. The socioeconomic status may interfere with BMI-per-age values, and the age group may interfere with weight-per-age and height-per-age indexes.

A fragilidade é composta por um tripé constituído por: sarcopenia, disfunção imunológica e desregulação neuroendócrina. A sarcopenia é definida como uma diminuição na força e na potência muscular, sendo que os músculos respiratórios também são afetados. O objetivo foi comparar a força muscular respiratória (FMR) em idosas residentes na comunidade, classificadas como não frágeis (NF), pré-frágeis (PF) e frágeis (F) e correlacionar a FMR com a força de preensão manual (FPM). O estudo foi do tipo transversal, com uma amostra de conveniência composta por 106 idosas. As participantes foram classificadas quanto ao fenótipo de fragilidade. A FMR foi avaliada por meio da pressão inspiratória máxima (PImáx) e da pressão expiratória máxima (PEmáx). Foram encontradas diferenças significativas da FMR entre os grupos NF e F (PImáx: p=0,001 e PEmáx: p<0,001) e entre os grupos PF e F (PImáx: p<0,001 e PEmáx: p<0,001). Em relação à FPM, foram observadas diferenças significativas entre todos os grupos (p<0,001). Houve correlação entre FMR e FPM apenas no grupo frágil. Desta forma, a FPM pode ser importante na prática clínica para diferenciar os subgrupos de fragilidade e identificar a perda de força muscular, incluindo a perda da FMR.

The fragility consist in a tripod comprising: sarcopenia, immune dysregulation, and neuroendocrine dysfunction. Sarcopenia is defined as a decrease in strength and muscle power, so that the respiratory muscles are also affected. The aim was to compare respiratory muscle strength (RMS) in elderly community residents, classified as nonfrail (NF), pre frail (PF) and frail (F), and correlate RMS with the handgrip strength (HS). The study was cross-sectional, with a convenience sample of 106 elderly women. Participants were classified according to the phenotype of frailty. The RMS was assessed by maximal inspiratory pressure (MIP) and maximum expiratory pressure (MEP). Significant differences were found in RMS between groups NF and F (MIP: p=0.001 and MEP: p<0.001) and between groups PF and F (MIP: p<0.001 and MEP: p<0.001). In relation to HS, significant differences were observed between all groups (p<0.001). There was correlation between HS and RMS only in the frail group. Thus, the HS may be important in the clinical evaluation to differentiate subgroups of fragility and identify the loss of muscle strength, including the loss of RMS.

La fragilidad está compuesta por un trípode constituido por: sarcopenia, disfunción inmunológica y desregulación neuroendócrina. La sarcopenia es definida como una disminución de la fuerza y de la potencia muscular, donde los músculos respiratorios también son afectados. El objetivo fue comparar la fuerza muscular respiratoria (FMR) en añosas residentes en la comunidad, clasificadas como no frágiles (NF), pre-frágiles (PF) y frágiles (F) y correlacionar la FMR con la fuerza de prensión manual (FPM). El estudio fue del tipo transversal, con una muestra de conveniencia compuesta por 106 añosas. Las participantes fueron clasificadas en cuanto al fenotipo de fragilidad. La FMR fue evaluada por medio de la presión inspiratoria máxima (PImáx) y de la presión expiratoria máxima (PEmáx). Fueron encontradas diferencias significativas de la FMR entre los grupos NF y F (PImáx: p=0,001 y PEmáx: p<0,001) y entre los grupos PF y F (PImáx: p<0,001 y PEmáx: p<0,001). En relación a la FPM, fueron observadas diferencias significativas entre todos los grupos (p<0,001). Hubo correlación entre FMR y FPM apenas en el grupo frágil. De esta forma, la FPM puede ser importante en la práctica clínica para diferenciar los subgrupos de fragilidad e identificar la pérdida de fuerza muscular, incluyendo la pérdida de la FMR.

O fator neurotrófico derivado do cérebro (BDNF) é uma neurotrofina envolvida na sobrevivência neuronal e no crescimento e diferenciação dos dendritos e axônios. O objetivo do presente estudo foi avaliar os níveis plasmáticos do BDNF de pacientes com hanseníase em diferentes fases da poliquimioterapia (PQT), em comparação com indivíduos não-infectados. Os níveis plasmáticos do BDNF foram mensurados pelo teste ELISA em 30 controles sadios e 37 pacientes com hanseníase no momento do diagnóstico, durante e após PQT. Os níveis plasmáticos do BDNF mostraram-se maiores nos indivíduos controles em comparação com os pacientes com hanseníase, mas não houve diferença estatisticamente significante. Curiosamente, os níveis de BDNF modificaram-se com o tratamento, mostrando diferença estatística apenas na segunda dose de PQT. Esses resultados indicam que o BDNF pode não ser um marcador de infecção na hanseníase e/ou neuropatias relacionadas. Novas pesquisas são necessárias para investigar o significado das alterações nos níveis de BDNF ao longo do tratamento da hanseníase.

Brain-derived neurotrophic factor (BDNF) is a neurotrophin involved in the survival of neurons and growth and differentiation of dendrites and axons. The purpose of the present study was to evaluate plasma levels of BDNF of leprosy patients at different stages of multidrug therapy (MDT) in comparison with non-infected individuals. Plasma levels of BDNF were measured by ELISA in 30 healthy controls and 37 leprosy patients at diagnosis, during and after MDT. Plasma levels of BDNF tended to be higher in control subjects in comparison with leprosy patients, but this difference does not reach statistical significance. Interestingly, BDNF levels changed following MDT, achieving statistical difference only at the 2nd dose of MDT. These results indicate that BDNF may not be a surrogate marker of leprosy infection and/or related neuropathy. Further research is needed to investigate the meaning of BDNF level changes following leprosy treatment.

A hanseníase é doença crônica infecciosa que se caracteriza por apresentar formas clínicas contrastantes, que são dependentes da interação do bacilo com a resposta imune do hospedeiro. O estudo dos processos imunológicos torna-se fundamental para o entendimento dos mecanismos envolvidos na apresentação e no desenvolvimento da doença. Neste artigo, é revisada a imunopatogênese da hanseníase.

Leprosy is a chronic infectious disease characterized by contrasting clinical forms that are dependent on the interactions between the bacillus and the host immune response. Thus, the study of the immunological process is extremely relevant for the comprehension of the mechanisms involved in leprosy presentation and development. In this paper, the immunopathogenesis of leprosy is reviewed.

Neste estudo, a expressão de receptores de quimiocinas na superfície dos leucócitos circulantes foi feita pela citometria de fluxo. Houve aumento da porcentagem de linfócitos CCR2+CD4+ no sangue periférico dos pacientes com hanseníase. Este resultado preliminar sugeriu alteração do perfil dos receptores de quimiocinas desses pacientes.

In this study, the expression of chemokine receptors on the surface of circulating leukocytes was determined using flow cytometry. An increase in the percentage of CCR2+CD4+ lymphocytes was observed in the peripheral blood of leprosy patients. This preliminary data suggests that alterations occur in the chemokine receptor profile of these patients.